Newsroom

As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation..

As we prepare to close the door on 2020, we asked Pantelis Vlachos, Principal/Strategic Consultant for Cytel, to share..

  As a part of Cytel’s "New Horizons Webinar Series", Alind Gupta, Senior Data Scientist, presents case studies from..

MUCE is a Bayesian solution for cohort expansion trials where multiple dose(s) and multiple indication(s) are tested in..

  Cytel recently conducted a webinar on Bayesian Dose-finding Designs for Modern Drug Development, presented by Dr...

Pharmaceutical and biotech companies are under pressure to deliver more and deliver faster with fewer resources. The..

In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel..

  Cytel and Novartis are together hosting a complimentary Bayesian Virtual Symposium and an Interactive 7-part..

Staying abreast of the rapid pace of clinical development means adopting innovative or computationally intensive..